BioNTech gibt geplanten Ruhestand von Sean Marett bekannt
07 mars 2024 06h45 HE
|
BioNTech SE
MAINZ, Deutschland, 7. März, 2024 – BioNTech SE (Nasdaq: BNTX, „BioNTech” oder “das Unternehmen”) gab heute bekannt, dass Sean Marett, Chief Business and Commercial Officer, in den Ruhestand gehen und...
BioNTech Announces Planned Retirement of Sean Marett
07 mars 2024 06h45 HE
|
BioNTech SE
Mainz, Germany, March 7, 2024 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced today that Sean Marett, Chief Business and Commercial Officer, will retire as planned...
BioNTech veröffentlicht am 20. März 2024 Ergebnisse für das vierte Quartal und das Geschäftsjahr 2023 und informiert über operativen Fortschritt
06 mars 2024 06h45 HE
|
BioNTech SE
MAINZ, Deutschland, 06. März 2024 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, „BioNTech” oder „das Unternehmen“) wird am Mittwoch, den 20. März 2023, die Ergebnisse für das vierte Quartal und das...
BioNTech to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on March 20, 2024
06 mars 2024 06h45 HE
|
BioNTech SE
MAINZ, Germany, March 6, 2024 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the full year and fourth quarter 2023 on Wednesday,...
BIONTECH SE (NASDAQ: BNTX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against BioNTech SE
04 mars 2024 07h30 HE
|
Bernstein Liebhard LLP
Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against BioNTech SE
BNTX DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages BioNTech SE Investors to Secure Counsel Before Important March 12 Deadline in Securities Class Action – BNTX
03 mars 2024 15h14 HE
|
The Rosen Law Firm PA
NEW YORK, March 03, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BioNTech SE (NASDAQ: BNTX) between March 30, 2022 and...
BNTX DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Counsel Before Important March 12 Deadline in Securities Class Action – BNTX
27 févr. 2024 19h49 HE
|
The Rosen Law Firm PA
NEW YORK, Feb. 27, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BioNTech SE (NASDAQ: BNTX) between March 30, 2022 and...
BIONTECH SE (NASDAQ: BNTX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against BioNTech SE
26 févr. 2024 16h00 HE
|
Bernstein Liebhard LLP
Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against BioNTech SE
BNTX DEADLINE ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages BioNTech SE Investors with Losses to Secure Counsel Before Important March 12 Deadline in Securities Class Action – BNTX
23 févr. 2024 16h37 HE
|
The Rosen Law Firm PA
NEW YORK, Feb. 23, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BioNTech SE (NASDAQ: BNTX) between March 30, 2022 and...
BIONTECH SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In BioNTech To Contact Him Directly To Discuss Their Options
23 févr. 2024 13h00 HE
|
Faruqi & Faruqi LLP
If you suffered losses exceeding $100,000 investing in BioNTech stock or options between March 30, 2022 and October 13, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi...